Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer

Liu, LP; Liu, H; Shao, D; Liu, Z; Wang, JJ; Deng, QH; Tang, HL; Yang, HH; Zhang, YL; Qiu, Y; Cui, F; Tan, MH; Zhang, P; Li, ZL; Liu, JL; Liang, WH; Wang, YY; Peng, ZY; Wang, J; Yang, HM; Mao, M; Kristiansen, K; Ye, MZ; He, JX

Ye, MZ; He, JX (reprint author), BGI Shenzhen, Shenzhen 518083, Peoples R China.; He, JX (reprint author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China.

GENES CHROMOSOMES & CANCER, 2018; 57 (4): 211

Abstract

Molecular analysis of potentially actionable mutations has become routine practice in oncological pathology. However, testing a wide range of oncogene......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索